Granite Point Capital Management, L.P. - Q3 2018 holdings

$1.51 Billion is the total value of Granite Point Capital Management, L.P.'s 116 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 49.4% .

 Value Shares↓ Weighting
DIA SellSPDR DOW JONES INDL AVRG ETFcall$132,200,000
-27.4%
500,000
-33.3%
8.77%
-46.2%
IWM SelliShares Russell 2000 Index (ETF)put$50,565,000
-64.3%
300,000
-65.3%
3.36%
-73.5%
EEM SellISHARES TRcall$25,752,000
-75.8%
600,000
-69.5%
1.71%
-82.1%
FXI SelliShares China Large-Cap (ETF)call$24,407,000
+9.8%
570,000
-36.7%
1.62%
-18.7%
AAPL SellAPPLE INCcall$14,899,000
+0.6%
66,000
-17.5%
0.99%
-25.5%
MRNS SellMARINUS PHARMACEUTICALS INC$10,594,000
-43.2%
1,059,367
-59.8%
0.70%
-57.9%
GOOS SellCANADA GOOSE HOLDINGS INC$6,280,000
+2.8%
97,300
-6.3%
0.42%
-23.8%
XENE SellXENON PHARMACEUTICALS INC$6,129,000
+38.2%
464,300
-3.7%
0.41%
+2.5%
TNDM SellTANDEM DIABETES CARE INC$5,998,000
+21.0%
140,000
-37.8%
0.40%
-10.4%
AMZN SellAMAZON COM INC$5,008,000
+9.1%
2,500
-7.4%
0.33%
-19.2%
TELL SellTELLURIAN INC NEW$4,872,000
-24.3%
543,100
-29.8%
0.32%
-43.9%
ZGNX SellZOGENIX INC$4,742,000
+8.9%
95,600
-2.9%
0.32%
-19.2%
SENS SellSENSEONICS HLDGS INC$4,467,000
-34.1%
936,400
-43.2%
0.30%
-51.3%
GLNG SellGOLAR LNG LTD BERMUDA$3,987,000
-31.0%
143,400
-26.9%
0.26%
-48.8%
ADMS SellADAMAS PHARMACEUTICALS INC$3,898,000
-25.3%
194,715
-3.7%
0.26%
-44.7%
RGNX SellREGENXBIO INC$3,586,000
-0.3%
47,500
-5.2%
0.24%
-26.1%
LULU SellLULULEMON ATHLETICA INC$3,510,000
+17.2%
21,600
-10.0%
0.23%
-13.1%
AXGN SellAXOGEN INC$3,500,000
-61.1%
94,976
-46.9%
0.23%
-71.2%
SellJDS UNIPHASE CORPdbcv 0.625% 8/1$3,316,000
-8.5%
3,300,000
-8.3%
0.22%
-32.3%
SRPT SellSAREPTA THERAPEUTICS INC$3,311,000
-9.6%
20,500
-26.0%
0.22%
-32.9%
AGS SellPLAYAGS INC$2,928,000
-2.0%
99,365
-10.0%
0.19%
-27.6%
LITE SellLUMENTUM HLDGS INC$2,632,000
-50.4%
43,900
-52.1%
0.18%
-63.2%
HIMX SellHIMAX TECHNOLOGIES INCsponsored adr$1,929,000
-45.6%
328,000
-30.9%
0.13%
-59.7%
ROKU SellROKU INC$1,767,000
+11.5%
24,200
-34.9%
0.12%
-17.6%
BABA SellALIBABA GROUP HLDG LTDsponsored ads$1,335,000
-32.1%
8,100
-23.6%
0.09%
-49.4%
ARPO SellAERPIO PHARMACEUTICALS INC$1,236,000
-60.3%
400,010
-46.7%
0.08%
-70.6%
GWPH SellGW PHARMACEUTICALS PLCads$1,140,000
+16.7%
6,600
-5.7%
0.08%
-13.6%
OLED SellUNIVERSAL DISPLAY CORP$825,000
+19.9%
7,000
-12.5%
0.06%
-11.3%
FBIO SellFORTRESS BIOTECH INC$768,000
-46.3%
479,835
-0.0%
0.05%
-60.2%
NPTN SellNEOPHOTONICS CORP$751,000
+26.2%
90,502
-5.2%
0.05%
-5.7%
EDU SellNEW ORIENTAL ED & TECH GRP Ispon adr$659,000
-51.7%
8,900
-38.2%
0.04%
-63.9%
OVID SellOVID THERAPEUTICS INC$634,000
-70.9%
111,826
-59.9%
0.04%
-78.5%
TAL SellTAL ED GROUPsponsored ads$630,000
-52.6%
24,500
-32.1%
0.04%
-64.7%
TWTR SellTWITTER INC$509,000
-41.4%
17,900
-10.1%
0.03%
-56.4%
TYL SellTYLER TECHNOLOGIES INC$490,000
+0.2%
2,000
-9.1%
0.03%
-25.0%
HCSG SellHEALTHCARE SVCS GRP INC$496,000
-15.5%
12,200
-10.3%
0.03%
-37.7%
NTES SellNETEASE INCsponsored adr$457,000
-39.7%
2,000
-33.3%
0.03%
-55.9%
RAIL SellFREIGHTCAR AMER INC$169,000
-13.8%
10,490
-10.3%
0.01%
-38.9%
BEDU SellBRIGHT SCHOLAR ED HLDGS LTDsponsored ads$155,000
-29.5%
12,533
-5.3%
0.01%
-50.0%
BTX ExitBIOTIME INC$0-37,791
-100.0%
-0.01%
LOVE ExitLOVESAC COMPANY$0-10,202
-100.0%
-0.02%
AXGT ExitAXOVANT SCIENCES LTD$0-100,000
-100.0%
-0.02%
AVXL ExitANAVEX LIFE SCIENCES CORP$0-100,000
-100.0%
-0.02%
APEN ExitAPOLLO ENDOSURGERY INC$0-50,000
-100.0%
-0.03%
WNC ExitWABASH NATL CORP$0-23,472
-100.0%
-0.04%
EEM ExitISHARES TRput$0-10,000
-100.0%
-0.04%
VSH ExitVISHAY INTERTECHNOLOGY INC$0-20,000
-100.0%
-0.04%
VECO ExitVEECO INSTRS INC DEL$0-40,000
-100.0%
-0.05%
NTGR ExitNETGEAR INC$0-10,000
-100.0%
-0.06%
SIEN ExitSIENTRA INC$0-35,400
-100.0%
-0.06%
ExitMAGNACHIP SEMICONDUCTOR SAnote 5.000% 3/0$0-500,000
-100.0%
-0.06%
BCOV ExitBRIGHTCOVE INC$0-77,900
-100.0%
-0.07%
CYRX ExitCRYOPORT INC$0-50,000
-100.0%
-0.07%
ECOR ExitELECTROCORE INC$0-50,000
-100.0%
-0.07%
MLCO ExitMELCO RESORT ENTERTAINMENT Ladr$0-30,400
-100.0%
-0.08%
MPAA ExitMOTORCAR PTS AMER INC$0-47,263
-100.0%
-0.08%
BAC ExitBANK AMER CORP$0-33,900
-100.0%
-0.09%
MDXG ExitMIMEDX GROUP INC$0-160,000
-100.0%
-0.09%
SCYX ExitSCYNEXIS INC$0-678,450
-100.0%
-0.10%
TWNK ExitHOSTESS BRANDS INCcl a$0-83,600
-100.0%
-0.10%
GTLS ExitCHART INDS INC$0-21,100
-100.0%
-0.12%
JPM ExitJPMORGAN CHASE & CO$0-12,600
-100.0%
-0.12%
STM ExitSTMICROELECTRONICS N Vny registry$0-60,000
-100.0%
-0.12%
GBT ExitGLOBAL BLOOD THERAPEUTICS IN$0-30,000
-100.0%
-0.12%
PFNX ExitPFENEX INC$0-258,500
-100.0%
-0.12%
SAGE ExitSAGE THERAPEUTICS INC$0-9,900
-100.0%
-0.14%
SGMS ExitSCIENTIFIC GAMES CORP$0-32,000
-100.0%
-0.14%
AMD ExitADVANCED MICRO DEVICES INC$0-110,000
-100.0%
-0.15%
CRCM ExitCARE COM INC$0-95,000
-100.0%
-0.18%
VCEL ExitVERICEL CORP$0-243,700
-100.0%
-0.21%
ExitLUMENTUM HLDGS INCnote 0.250% 3/1$0-2,000,000
-100.0%
-0.21%
FNTE ExitFINTECH ACQUISITION CORP II$0-400,000
-100.0%
-0.36%
GLD ExitSPDR GOLD TRUST$0-36,200
-100.0%
-0.38%
CELG ExitCELGENE CORPcall$0-100,000
-100.0%
-0.71%
VRTX ExitVERTEX PHARMACEUTICALS INCcall$0-60,000
-100.0%
-0.91%
MS ExitMORGAN STANLEYcall$0-500,000
-100.0%
-2.12%
JPM ExitJPMORGAN CHASE & COcall$0-500,000
-100.0%
-4.67%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-11-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
META PLATFORMS INC37Q1 20233.9%
AMAZON COM INC33Q1 20235.9%
ALIBABA GROUP HLDG LTD30Q1 20231.7%
TAL EDUCATION GROUP28Q4 20220.9%
ISHARES TR27Q2 202255.1%
ALPHABET INC25Q1 20232.7%
APPLE INC25Q1 20232.3%
AXOGEN INC24Q1 20222.5%
RINGCENTRAL INC24Q4 20220.7%
ADVANCED MICRO DEVICES INC22Q1 20238.5%

View Granite Point Capital Management, L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)
Granite Point Capital Management, L.P. Q3 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Neuronetics, Inc.Sold outJanuary 26, 202200.0%
Sientra, Inc.February 12, 20212,396,0004.7%
MARINUS PHARMACEUTICALS INCJanuary 27, 20201,368,8111.6%

View Granite Point Capital Management, L.P.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2023-11-07
13F-HR2023-08-10
13F-HR2023-05-11
13F-HR2023-02-07
13F-HR2022-11-04
13F-HR2022-08-05
13F-HR2022-05-11
13F-HR2022-02-11
SC 13G/A2022-01-26
13F-HR2021-11-10

View Granite Point Capital Management, L.P.'s complete filings history.

Compare quarters

Export Granite Point Capital Management, L.P.'s holdings